𝔖 Bobbio Scriptorium

✦ LIBER ✦

85 A prospective randomised study in limited disease small cell carcinoma-doxorubicin and vincristine plus either cyclophosphamide or etoposide

✍ Scribed by R.P. Abratt; P.A. Willcor; D.G.M. Salton; J.R. Malan

Book ID: 116166841
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 159 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95337-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective randomised study in limite

A prospective randomised study in limited disease small cell carcinoma—Doxorubicin and vincristine plus either cyclophosphamide or etoposide

✍ R.P. Abratt; D.G.M. Salton; J.R. Malan; P.A. Willcox 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 382 KB

A prospective randomised study in limite

A prospective randomised study in limited disease small cell carcinoma—doxorubicin and vincristine plus either cyclophosphamide or etoposide

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Etoposide combined with cyclophosphamide

Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: A randomized trial of the Bristol Lung Cancer Study Group

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Comparison of cyclophosphamide, doxorubi

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: A Mid-Atlantic Oncology Program study

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Carboplatin and etoposide (CarE) followe

Carboplatin and etoposide (CarE) followed by vincristine, doxorubicin and cyclophosphamide (VAC) combined with raditherapy (RT) in Limited Small Cell Lung Cancer (SCLC). A phase II study

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A randomized, controlled phase III study

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses

✍ Diego Tummarello; Davide Mari; Francesco Graziano; Pierpaolo Isidori; Gianluigi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

BACKGROUND. Studies of chemotherapy for